ABUS vs WST · P/E 5.4, rev $6.2M vs P/E 35, rev $2.89B
Arbutus Biopharma Corp (ABUS) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the ABUS and WST stock pages for the full models.
Not investment advice.